| Financial Year |
March 31 2023 |
| Monetary Funds |
9,653,822,897.48 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
799,399,901.62 |
| Accounts Receivable |
10,604,172,517.92 |
| Advances to Suppliers |
1,797,673,872.48 |
| Other Receivables |
3,613,711,950.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
23,699,964.63 |
| Inventories |
3,328,428,489.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
302,845,158.44 |
| Other Current Assets |
6,346,204,583.44 |
| Total Current Assets |
76,248,546,983.92 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
8,458,254,281.10 |
| Long-term Equity Investment |
6,708,616,665.18 |
| Investment Properties |
323,992,169.90 |
| Fixed Assetes |
3,527,451,968.72 |
| Under-construction Projects |
4,661,738,801.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
402,190,920.81 |
| R&D expenses |
12,527,700.73 |
| Goodwill |
221,317,548.72 |
| Long-Term Deferred and Prepaid Expenses |
143,787,611.61 |
| Deferred Income Tax Assets |
443,289,758.24 |
| Other Non-Current Assets |
872,515,316.14 |
| Sub-Total of Non-Current Assets |
31,501,293,520.08 |
| Total Assets |
107,749,840,504.00 |
| Short-Term Loans |
8,873,893,816.05 |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,653,040,086.99 |
| Accounts Payable |
37,415,526,879.32 |
| Accounts Received In Advance |
8,578,935.56 |
| Employee Compensation Payable |
208,598,036.51 |
| Taxes Payable |
452,845,408.20 |
| Interest Payable |
-- |
| Dividend Payable |
7,746,256.42 |
| Other payables |
3,790,701,958.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
664,047,820.41 |
| Other Current Liabilities |
6,014,035,091.10 |
| Sub-Total of Current Liabilities |
66,634,596,524.63 |
| Long-term Loans |
9,138,557,856.65 |
| Bonds Payable |
6,958,726,313.99 |
| Long-Term Accounts Payable |
679,714,903.44 |
| Special Payable |
-- |
| Estimatied Liabilities |
27,592,736.64 |
| Deferred Income Tax Liabilities |
197,718,880.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
17,437,993,771.45 |
| Total Liabilities |
84,072,590,296.08 |
| Paid-In Capital(Or Share Stock) |
2,152,514,780.33 |
| Capital Surplus |
1,291,220,294.08 |
| Surplus Reserve |
706,179,923.04 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
8,629,538,696.99 |
| Minority Stockholder's Interest |
7,119,438,846.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
16,557,811,361.53 |
| Owner's Equity（Stockholder's Equity） |
23,677,250,207.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
107,749,840,504.00 |
